Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.6K Buy
562
+203
+57% +$9.12K ﹤0.01% 2842
2026
Q2
$16.6K Buy
359
+3
+0.8% +$121 ﹤0.01% 2945
2026
Q1
$11.8K Buy
356
+94
+36% +$3.06K ﹤0.01% 2986
2025
Q4
$8.57K Buy
262
+72
+38% +$1.77K ﹤0.01% 3044
2025
Q3
$3.39K Buy
190
+83
+78% +$1.2K ﹤0.01% 3317
2025
Q2
$1.16K Sell
107
-201
-65% -$2.63K ﹤0.01% 3510
2025
Q1
$5.7K Buy
308
+165
+115% +$2.98K ﹤0.01% 3032
2024
Q4
$2.36K Buy
143
+40
+39% +$566 ﹤0.01% 3170
2024
Q3
$1.44K Buy
103
+80
+348% +$885 ﹤0.01% 3159
2024
Q2
$167 Buy
+23
New +$157 ﹤0.01% 3372

Other funds holding AXGN

GAMMA Investing's AXGN Position: Q3 2026 in Review

GAMMA Investing increased its Axogen (AXGN) stake by 57% in Q3 2026, buying an estimated $9.12K and bringing the position to 562 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2842.

GAMMA Investing first reported a position in AXGN in Q2 2024 and has held it in 10 quarters since. 11 funds tracked by Wall St. Rank hold AXGN as of Q3 2026.

  • GAMMA Investing held 562 shares of Axogen worth $23.6K as of Q3 2026.
  • GAMMA Investing bought 203 Axogen shares in Q3 2026, an estimated $9.12K.
  • Axogen made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2842 holding.
  • GAMMA Investing first reported a position in Axogen in Q2 2024 and has held it in 10 quarters since.
  • 11 funds tracked by Wall St. Rank held Axogen as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.